Highlights Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Delayed NSE India S.E. Other stock markets 05:50:17 29/05/2024 BST			5-day change	1st Jan Change
5,367 ^INR	+1.01%		+1.13%	+3.10%

04-16	Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak	CI
03-28	Alkem Laboratories Forms Subsidiary for Medical Devices Business	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Alkem Laboratories Forms Subsidiary for Medical Devices Business	03-28	MT
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	03-28	CI
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	03-28	MT
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	02-12	MT
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	02-09	CI
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.	01-10	CI
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India	12-12	CI
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy	12-12	CI
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate	12-12	MT
Alkem Laboratories Gets Three Observations from US FDA After Mandva, India Unit Inspection	12-04	MT
Alkem Laboratories' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 6%	11-08	MT
Alkem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-07	CI
Alkem Laboratories Limited and Biosergen AB Enter into a Co-Development and License Agreement	25/09/23	CI
Alkem Laboratories' Consolidated Profit Jumps in Fiscal Q1; Shares Drop 7%	11/08/23	MT
Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
India drug regulator finds counterfeit medicines worth 20 million rupees in raid	03/08/23	RE
Alkem Laboratories Forays into Ophthalmology Business	07/07/23	MT
Alkem Laboratories' Consolidated Profit Drops in Fiscal Q4	19/05/23	MT
Alkem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	19/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Highlights

Filters